
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An in vivo drug repurposing screen and transcriptional analyses reveals the serotonin pathway and GSK3 as major therapeutic targets for NGLY1 deficiency
Kevin A. Hope, Alexys R. Berman, Randall T. Peterson, et al.
PLoS Genetics (2022) Vol. 18, Iss. 6, pp. e1010228-e1010228
Open Access | Times Cited: 13
Kevin A. Hope, Alexys R. Berman, Randall T. Peterson, et al.
PLoS Genetics (2022) Vol. 18, Iss. 6, pp. e1010228-e1010228
Open Access | Times Cited: 13
Showing 13 citing articles:
Exome/Genome Sequencing in Undiagnosed Syndromes
Jennifer A. Sullivan, Kelly Schoch, Rebecca C. Spillmann, et al.
Annual Review of Medicine (2023) Vol. 74, Iss. 1, pp. 489-502
Open Access | Times Cited: 27
Jennifer A. Sullivan, Kelly Schoch, Rebecca C. Spillmann, et al.
Annual Review of Medicine (2023) Vol. 74, Iss. 1, pp. 489-502
Open Access | Times Cited: 27
Generation and characterization of NGLY1 patient-derived midbrain organoids
Joshua M. Abbott, Mitali A. Tambe, Ivan Pavlinov, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 11
Joshua M. Abbott, Mitali A. Tambe, Ivan Pavlinov, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 11
The Therapeutic Future for Congenital Disorders of Glycosylation
Irena Muffels, Tamás Kozicz, Ethan Perlstein, et al.
Journal of Inherited Metabolic Disease (2025) Vol. 48, Iss. 2
Closed Access
Irena Muffels, Tamás Kozicz, Ethan Perlstein, et al.
Journal of Inherited Metabolic Disease (2025) Vol. 48, Iss. 2
Closed Access
NGLY1: A fascinating, multifunctional molecule
Tadashi Suzuki, Haruhiko Fujihira
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1868, Iss. 2, pp. 130379-130379
Closed Access | Times Cited: 7
Tadashi Suzuki, Haruhiko Fujihira
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1868, Iss. 2, pp. 130379-130379
Closed Access | Times Cited: 7
Quantifying Kinematic Tremor in an NGLY1-Deficient Individual: A Case Study
Brock Futrell, Christopher A. Malaya, Dacia Martinez Diaz, et al.
Case Reports in Clinical Medicine (2024) Vol. 13, Iss. 01, pp. 25-36
Open Access | Times Cited: 2
Brock Futrell, Christopher A. Malaya, Dacia Martinez Diaz, et al.
Case Reports in Clinical Medicine (2024) Vol. 13, Iss. 01, pp. 25-36
Open Access | Times Cited: 2
Strategies for dissecting the complexity of neurodevelopmental disorders
Jiawan Sun, Serena M. Noss, Deepro Banerjee, et al.
Trends in Genetics (2023) Vol. 40, Iss. 2, pp. 187-202
Closed Access | Times Cited: 5
Jiawan Sun, Serena M. Noss, Deepro Banerjee, et al.
Trends in Genetics (2023) Vol. 40, Iss. 2, pp. 187-202
Closed Access | Times Cited: 5
Drosophila models of phosphatidylinositol glycan biosynthesis class A congenital disorder of glycosylation (PIGA-CDG) mirror patient phenotypes
Holly J. Thorpe, Katie G Owings, Miriam C. Aziz, et al.
G3 Genes Genomes Genetics (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 4
Holly J. Thorpe, Katie G Owings, Miriam C. Aziz, et al.
G3 Genes Genomes Genetics (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 4
A drug repurposing screen reveals dopamine signaling as a critical pathway underlying potential therapeutics for the rare disease DPAGT1-CDG
Hans M. Dalton, Naomi Young, Alexys R. Berman, et al.
PLoS Genetics (2024) Vol. 20, Iss. 10, pp. e1011458-e1011458
Open Access | Times Cited: 1
Hans M. Dalton, Naomi Young, Alexys R. Berman, et al.
PLoS Genetics (2024) Vol. 20, Iss. 10, pp. e1011458-e1011458
Open Access | Times Cited: 1
Ever-expanding NGLY1 biology
Tadashi Suzuki, Yasuko Yoshida
The Journal of Biochemistry (2021) Vol. 171, Iss. 2, pp. 141-143
Open Access | Times Cited: 9
Tadashi Suzuki, Yasuko Yoshida
The Journal of Biochemistry (2021) Vol. 171, Iss. 2, pp. 141-143
Open Access | Times Cited: 9
A drug repurposing screen reveals dopamine signaling as a critical pathway underlying potential therapeutics for the rare disease DPAGT1-CDG
Hans M. Dalton, Naomi J Young, Alexys R. Berman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Hans M. Dalton, Naomi J Young, Alexys R. Berman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Editorial: Community series in recent advances in Drosophila cellular and humoral innate immunity: volume II
Laura Vesala, Dan Hultmark, Susanna Valanne
Frontiers in Immunology (2024) Vol. 15
Open Access
Laura Vesala, Dan Hultmark, Susanna Valanne
Frontiers in Immunology (2024) Vol. 15
Open Access
Pharmacological rescue of motor circuit dysfunction in a Drosophila model of paroxysmal dyskinesia
Abigail D. Wilson, Yuyao Jiang, Nidhika Desai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Abigail D. Wilson, Yuyao Jiang, Nidhika Desai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
A commentary on ‘Patient-derived gene and protein expression signatures of NGLY1 deficiency’
Tadashi Suzuki
The Journal of Biochemistry (2023) Vol. 175, Iss. 3, pp. 221-223
Open Access
Tadashi Suzuki
The Journal of Biochemistry (2023) Vol. 175, Iss. 3, pp. 221-223
Open Access